EPHA2 and osteosarcoma: Ephrin-A1 binding to EPHA2, which is not expressed in normal bone but is overexpressed in osteosarcoma, induces increased tyrosine phosphorylation and activation of downstream signaling pathways mediated by MAPK activation, possibly stimulating osteosarcoma’s metastatic potential [113].